Prostate Cancer - Results from #24540

Outcomes of expanded use of PCA3 testing in a Spanish population with clinical suspicion of prostate cancer - Abstract July 13, 2011

Relationship between prostate-specific antigen bounce body fat distribution and body mass index in permanent seed brachytherapy for prostate cancer - Abstract July 13, 2011

Prostate cancer immunotherapy - Abstract July 13, 2011

Role of MRI in minimally invasive focal ablative therapy for prostate cancer - Abstract July 13, 2011

Optimal duration of androgen deprivation in combination with radiation therapy for Japanese men with high-risk prostate cancer - Abstract July 13, 2011

NIH-funded study shows reduction in death for men with intermediate-grade prostate cancer July 13, 2011

The push towards primary care: Views of health professionals on the role of primary care in the follow-up of men with prostate cancer - Abstract July 12, 2011

Differences in disease presentation, treatment outcomes, and toxicities in African American patients treated with radiation therapy for prostate cancer - Abstract July 12, 2011

Androgen deprivation therapy and definitive radiotherapy for prostate cancer - Abstract July 12, 2011

Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer - Abstract July 12, 2011

Interactive digital slides with heat maps: A novel method to improve the reproducibility of Gleason grading - Abstract July 12, 2011

Prostate cancer: Utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization - Abstract July 12, 2011

Editor's Commentary - Predicting 15-year prostate cancer specific mortality after radical prostatectomy July 12, 2011

Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: A decision analysis - Abstract July 11, 2011

An update on TroVax for the treatment of progressive castration-resistant prostate cancer - Abstract July 11, 2011

Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): Detection of cancer after multiple negative systematic random and in primary biopsies - Abstract July 11, 2011

Impact of race on biochemical disease recurrence after prostate brachytherapy - Abstract July 11, 2011

Hospital racial composition and the treatment of localized prostate cancer - Abstract July 11, 2011

From clinical trials to clinical practice: Therapeutic cancer vaccines for the treatment of prostate cancer - Abstract July 11, 2011

Prostate cancer detection after a negative prostate biopsy: Lessons learnt in the Cleveland Clinic experience - Abstract July 11, 2011

Page 1228 of 1288